|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 221/28 | (2006.01) |
| C07B 59/00 | (2006.01) | ||
| A61K 31/439 | (2006.01) | ||
| A61P 11/14 | (2006.01) |
| (11) | Number of the document | 3825306 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20200633.4 |
| Date of filing the European patent application | 2008-04-30 | |
| (97) | Date of publication of the European application | 2021-05-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation | 2023-08-10 |
| (30) | Number | Date | Country code |
| 91513007 P | 2007-05-01 | US | |
| 91666207 P | 2007-05-08 | US | |
| 97604407 P | 2007-09-28 | US |
| (72) |
TUNG, Roger , US
|
| (73) |
Sun Pharmaceutical Industries, Inc. ,
2 Independence Way, Princeton, NJ 08540,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Morfinano junginiai |
| MORPHINAN COMPOUNDS |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 18 | 347.00 EUR |
| 2026-04-30 |